Membership: | Free |
Person Marks: | 16 |
Total Posts: | 0 |
Total Blog Posts: | 0 |
Total Compensated Posts: | 0 |
Moderating: | 0 |
Alias Born: | 06/22/2016 6:32:14 PM |
CLWD | CloudCommerce is a public company, traded on the OTC with the symbol, CLWD |
---|---|
About: | CloudCommerce, Inc. is a global provider of cloud-driven e-commerce and mobile commerce solutions. Through our wholly owned subsidiaries, we provide online merchants and leading brands with complete solutions for successfully conducting business with customers anytime, anywhere and on any device. Whether it is selling products or services online or making business processes available on the cloud, we deliver solutions that maximize user experience with real-time integration to enterprise applications. We focus intently on four main areas to deliver exceptional value to our customers: engaging frontend design, robust backend integration, effective digital marketing and analytics, and complete solutions management. To better serve our customers and create value for our shareholders, we strategically acquire profitable cloud commerce solutions providers with strong management teams. To learn more, please visit: http://cloudcommerce.com/ |
Recent Articles
- Soleno Therapeutics Faces Investigation Over Securities Practices
- Understanding the Recent Legal Developments Surrounding Lantheus
- Brunello Cucinelli Under Scrutiny Amid Allegations of Misconduct
- Investigation Launched Into Stitch Fix, Inc. by Pomerantz Law
- Investigation Alert: Trinseo PLC Faces Securities Claims
- Investigation into Reddit, Inc.: Potential Securities Fraud Claims
- Investigation into Acadia Pharmaceuticals Amid Legal Concerns
- Nutex Health Under Legal Fire Amid Revenue Inflation Accusations
- Unlocking Efficiency: Affordable Virtual Staffing with VirtuAssist
- Exploring Underrated Stocks: Insights on Market Opportunities
- Investors Alert: Class Action for Brunello Cucinelli S.p.A.
- Unveiling the Future: AI Pavilion Launches at Global Sources
- Sichuan Promotes Cultural Tourism Globally with New Logo
- Vera Bradley Faces Investor Scrutiny Amid Financial Concerns
- Families Carrying On the Haunted Legacy of Frightful Fun
- Understanding Your Rights After Freeport-McMoRan Stock Losses
- NuCana Showcases Promising Results of NUC-7738 in Cancer Therapy
- MorseLife's Recognition: A Testament to Commitment and Care
- Innovative Mutual Finance Attracts Thousands with DeFi Launch
- Exploring the Insights from the CDFG Consumer White Paper 2024-2025
- Latest Market Updates: Stocks Show Mixed Responses Amid Changes
- Investigation Looms Over Guess?, Inc. Merger with Authentic Brands
- Investigating Jefferies Financial Group Inc.: What You Need to Know
- Molina Healthcare Investors: Important Legal Actions Ahead
- Promising Results for Rinatabart Sesutecan in Cancer Treatment
- Nuvalent Unveils Promising Insights on Neladalkib for ALK Cancer
- United Airlines Incident: Tarmac Collision at O'Hare Airport
- Samsung Chairman's Family Sells Shares to Meet Inheritance Tax
- Clinical Breakthrough: ITM's Promising Trial Results Unveiled
- Celcuity's Promising Phase 1 Trial Results on Prostate Cancer Therapy
- New Findings on Gedatolisib’s Efficacy for Advanced Breast Cancer
- Concerns Raised Over Elon Musk's Striking Compensation Package
- Qustodio: Elevating Digital Child Safety on iPhones in 2025
- Celcuity's Phase 3 VIKTORIA-1 Trial for PIK3CA Mutants Advances
- Innovative Gedatolisib and Darolutamide Study Shows Promise
- New Insights on Gedatolisib's Role in Breast Cancer Treatment
- Meta and Blue Owl Collaborate on $30 Billion AI Data Center
- Kura Oncology's Latest Insights on FTI Program Advancements
- Nvidia's Market Share Plummets: CEO Jensen Huang's Concerns
- Kura Oncology Unveils Promising Data from FTI Programs at ESMO
- Olema Oncology Shares Promising Findings on Palazestrant
- General Oncology's SHARON Trial Yields Encouraging Results
- Revitalizing ER+ Breast Cancer with Palazestrant and Ribociclib
- Corbus Pharmaceuticals Reports Promising Results for CRB-701
- Promising Data on NX-1607: A Breakthrough in Cancer Treatment
- Florida Cancer Specialists Revolutionizing Oncology Research
- Salesforce CEO's Apology Sparks Controversy in Tech Industry
- Significant Progress in Advanced Breast Cancer Treatments with Giredestrant
- Breakthrough in HPV Carcinoma Treatment by SCG Cell Therapy
- Innovative Immunotherapy SCG142 Shows Promise in Cancer Treatment